Boston Scientific Corporation
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Boston Scientific Corporation
RECRUITINGNCT07377487
TheraSphere Japan Pre-Market Study
To investigate the safety and effectiveness of BSJ019T in Japanese patients with primary or secondary liver who are not candidate for standard treatment.
Sponsor: Boston Scientific CorporationEnrolling: 514 locations
Liver Neoplasms
RECRUITINGNCT07106970
PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)
This study is a prospective, multicenter, open-label, randomized controlled trial to investigate whether a linear ablation in addition to pulmonary vein isolation (PVI)...
Sponsor: Boston Scientific CorporationEnrolling: 6401 location
Persistent Atrial Fibrillation
RECRUITINGNCT06735534
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE...
The ReMATCH Study is a prospective, single arm, open label, multi-center, study utilizing the FARAPULSE PFA System, including the FARAWAVE and FARAPOINT PFA Catheters.
Sponsor: Boston Scientific CorporationEnrolling: 37620 locations
Persistent Atrial Fibrillation